Kyowa Kirin (4151) Sustainability Meeting Presentation summary

Kyowa Kirin's sustainability approach

• Pursues co-creation of life-changing value with stakeholders, aiming for both social and economic value through CSV management.

• Focuses on solving social issues by providing innovative treatments and reinvesting profits into human and intellectual capital.

• Commits to reducing environmental impact for future generations as part of sustainable business activities.

Vision 2030 and value creation strategy

• Aims to be a Japan-based global specialty pharmaceutical company delivering life-changing value by addressing unmet medical needs.

• Focuses on bone & mineral, intractable hematological diseases, hemato-oncology, and rare diseases.

• Leverages advanced antibody technologies, gene therapy, and digital transformation to drive innovation.

• Implements open innovation and strategic partnerships to maximize product value and accelerate delivery to patients.

Core strategies and materiality

• Prioritizes creation of innovative drugs, maximizing product value, and enriching the pipeline.

• Ensures quality assurance, stable supply, and reduced environmental impact.

• Enhances access to medicine and develops healthcare solutions beyond pharmaceuticals.

• Strengthens human resources, digital transformation, and corporate governance.